Refine
Departments, institutes and facilities
- Fachbereich Wirtschaftswissenschaften (1241)
- Fachbereich Informatik (1148)
- Fachbereich Angewandte Naturwissenschaften (766)
- Fachbereich Ingenieurwissenschaften und Kommunikation (636)
- Institut für funktionale Gen-Analytik (IFGA) (584)
- Institut für Technik, Ressourcenschonung und Energieeffizienz (TREE) (485)
- Präsidium (404)
- Fachbereich Sozialpolitik und Soziale Sicherung (402)
- Institute of Visual Computing (IVC) (313)
- Institut für Cyber Security & Privacy (ICSP) (307)
Document Type
- Article (2431)
- Conference Object (1806)
- Part of a Book (942)
- Book (monograph, edited volume) (452)
- Part of Periodical (411)
- Report (201)
- Contribution to a Periodical (118)
- Doctoral Thesis (106)
- Working Paper (94)
- Preprint (90)
Year of publication
Keywords
- Lehrbuch (88)
- Deutschland (34)
- Nachhaltigkeit (30)
- Controlling (25)
- Unternehmen (25)
- Management (20)
- Corporate Social Responsibility (18)
- Betriebswirtschaftslehre (17)
- Digitalisierung (17)
- Machine Learning (17)
Background: Type 2 diabetes mellitus is associated with increased cardiovascular risk. One laboratory marker for cardiovascular risk assessment is high-sensitivity C-reactive protein (hsCRP).
Methods: This cross-sectional study attempted to analyze the association of hsCRP levels with insulin resistance, β-cell dysfunction and macrovascular disease in 4270 non-insulin-treated patients with type 2 diabetes [2146 male, 2124 female; mean age ±SD, 63.9±11.1years; body mass index (BMI) 30.1±5.5kg/m2; disease duration 5.4±5.6years; hemoglobin A1c (HbA1c) 6.8±1.3%]. It consisted of a single morning visit with collection of a fasting blood sample. Observational parameters included several clinical scores and laboratory biomarkers.
Results: Stratification into cardiovascular risk groups according to hsCRP levels revealed that 934 patients had low risk (hsCRP <1mg/L), 1369 patients had intermediate risk (hsCRP 1–3mg/L), 1352 patients had high risk (hsCRP >3–10mg/L), and 610 patients had unspecific hsCRP elevation (>10mg/L). Increased hsCRP levels were associated with other indicators of diabetes-related cardiovascular risk (homeostatic model assessment, intact proinsulin, insulin, BMI, β-cell dysfunction, all p<0.001), but showed no correlation with disease duration or glucose control. The majority of the patients were treated with diet (34.1%; hsCRP levels 2.85±2.39mg/L) or metformin monotherapy (21.1%; 2.95±2.50mg/L hsCRP). The highest hsCRP levels were observed in patients treated with sulfonylurea (17.0%; 3.00±2.43mg/L).
Conclusions: Our results indicate that hsCRP may be used as a cardiovascular risk marker in patients with type 2 diabetes mellitus and should be evaluated in further prospective studies.
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus
(2006)
Eine Suite für den Patienten
(2006)